DCI Insider: Dahlgren Exercises 3,000 Options and Sells 3,000 Shares
Rhea-AI Filing Summary
Andrew C. Dahlgren, President and director of Donaldson Company, Inc. (DCI), reported option exercise and an offsetting sale on 08/28/2025. He exercised an employee stock option to acquire 3,000 shares at an exercise price of $28.00 per share and concurrently sold 3,000 shares at $81.96 per share. After these transactions the filing shows 7,504 shares owned directly. The filing notes the option was fully vested and that there are 0 derivative securities beneficially owned following the reported transactions. The Form 4 is signed by Amy C. Becker as attorney-in-fact on 09/02/2025.
Positive
- Exercise of employee stock option for 3,000 shares at a $28.00 exercise price is disclosed
- Options were fully vested at time of exercise, as explicitly stated
- Filing is complete and signed (attorney-in-fact signature dated 09/02/2025)
Negative
- Disposition of 3,000 shares via sale at $81.96 reduced direct holdings to 7,504 shares
- No cash or total proceeds disclosed in the Form 4 for the sale transaction
Insights
TL;DR: Insider exercised 3,000 options at $28 and sold 3,000 shares at $81.96, leaving 7,504 shares directly owned.
The transaction is a routine option exercise and simultaneous sale by a senior executive. Economically, the exercise price of $28 versus the sale price of $81.96 implies a substantial per-share spread, but the filing provides no cash totals or intended use of proceeds. The report shows the exercised options were fully vested and that no derivative holdings remain after the transactions, which is typical after exercise-and-sell activity designed to capture intrinsic value while reducing option exposure.
TL;DR: This is a standard Section 16 disclosure for a vested option exercise and sale by a reporting officer.
The filing identifies Dahlgren as President and a reporting person and documents the exercise and sale on the same date, consistent with common insider liquidity events. The Form 4 is properly signed by an attorney-in-fact and discloses post-transaction holdings. There are no indications in the filing of unusual trading patterns, pledges, or derivative retention that would raise immediate governance concerns.